These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 14535878
41. Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII. Biswas S, McKenna R, Supuran CT. Bioorg Med Chem Lett; 2013 Oct 15; 23(20):5646-9. PubMed ID: 23993330 [Abstract] [Full Text] [Related]
42. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Thiry A, Dogné JM, Masereel B, Supuran CT. Trends Pharmacol Sci; 2006 Nov 15; 27(11):566-73. PubMed ID: 16996620 [Abstract] [Full Text] [Related]
43. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O'Byrne KJ. J Clin Oncol; 2003 Feb 01; 21(3):473-82. PubMed ID: 12560438 [Abstract] [Full Text] [Related]
44. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT. Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3102-8. PubMed ID: 15905091 [Abstract] [Full Text] [Related]
45. Discovering novel carbonic anhydrase type IX (CA IX) inhibitors from seven million compounds using virtual screening and in vitro analysis. Salmas RE, Senturk M, Yurtsever M, Durdagi S. J Enzyme Inhib Med Chem; 2016 Jun 15; 31(3):425-33. PubMed ID: 25950196 [Abstract] [Full Text] [Related]
47. Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells. Li Y, Wang H, Oosterwijk E, Tu C, Shiverick KT, Silverman DN, Frost SC. Cancer Invest; 2009 Jul 15; 27(6):613-23. PubMed ID: 19367501 [Abstract] [Full Text] [Related]
53. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors. Rosatelli E, Carotti A, Ceruso M, Supuran CT, Gioiello A. Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3422-5. PubMed ID: 24948563 [Abstract] [Full Text] [Related]
54. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII. Esirden İ, Ulus R, Aday B, Tanç M, Supuran CT, Kaya M. Bioorg Med Chem; 2015 Oct 15; 23(20):6573-80. PubMed ID: 26422787 [Abstract] [Full Text] [Related]
59. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. Winum JY, Pastorekova S, Jakubickova L, Montero JL, Scozzafava A, Pastorek J, Vullo D, Innocenti A, Supuran CT. Bioorg Med Chem Lett; 2005 Feb 01; 15(3):579-84. PubMed ID: 15664816 [Abstract] [Full Text] [Related]
60. Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours. Kivelä AJ, Parkkila S, Saarnio J, Karttunen TJ, Kivelä J, Parkkila AK, Pastoreková S, Pastorek J, Waheed A, Sly WS, Rajaniemi H. Histochem Cell Biol; 2000 Sep 01; 114(3):197-204. PubMed ID: 11083462 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]